img

Global Biotech Drug Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Biotech Drug Market Research Report 2024

Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin, interferon, and monoclonal antibody (mAb) products.
According to Mr Accuracy reports’s new survey, global Biotech Drug market is projected to reach US$ 674510 million in 2029, increasing from US$ 468270 million in 2022, with the CAGR of 8.7% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Biotech Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Biotech Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Biogen
Celltrion
Sobi
3SBIO
Changchun High Tech
Kanghong Pharma
Innovent Biologics
Gan&Lee
Tonghua Dongbao
United Laboratory
Segment by Type
Monoclonal Antibodies
Interferon
Insulin
Vaccines
Others

Segment by Application


Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Biotech Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biotech Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Insulin
1.2.5 Vaccines
1.2.6 Others
1.3 Market by Application
1.3.1 Global Biotech Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biotech Drug Market Perspective (2018-2029)
2.2 Biotech Drug Growth Trends by Region
2.2.1 Global Biotech Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Biotech Drug Historic Market Size by Region (2018-2024)
2.2.3 Biotech Drug Forecasted Market Size by Region (2024-2029)
2.3 Biotech Drug Market Dynamics
2.3.1 Biotech Drug Industry Trends
2.3.2 Biotech Drug Market Drivers
2.3.3 Biotech Drug Market Challenges
2.3.4 Biotech Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biotech Drug Players by Revenue
3.1.1 Global Top Biotech Drug Players by Revenue (2018-2024)
3.1.2 Global Biotech Drug Revenue Market Share by Players (2018-2024)
3.2 Global Biotech Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biotech Drug Revenue
3.4 Global Biotech Drug Market Concentration Ratio
3.4.1 Global Biotech Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biotech Drug Revenue in 2022
3.5 Biotech Drug Key Players Head office and Area Served
3.6 Key Players Biotech Drug Product Solution and Service
3.7 Date of Enter into Biotech Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biotech Drug Breakdown Data by Type
4.1 Global Biotech Drug Historic Market Size by Type (2018-2024)
4.2 Global Biotech Drug Forecasted Market Size by Type (2024-2029)
5 Biotech Drug Breakdown Data by Application
5.1 Global Biotech Drug Historic Market Size by Application (2018-2024)
5.2 Global Biotech Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Biotech Drug Market Size (2018-2029)
6.2 North America Biotech Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Biotech Drug Market Size by Country (2018-2024)
6.4 North America Biotech Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biotech Drug Market Size (2018-2029)
7.2 Europe Biotech Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Biotech Drug Market Size by Country (2018-2024)
7.4 Europe Biotech Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biotech Drug Market Size (2018-2029)
8.2 Asia-Pacific Biotech Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Biotech Drug Market Size by Region (2018-2024)
8.4 Asia-Pacific Biotech Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biotech Drug Market Size (2018-2029)
9.2 Latin America Biotech Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Biotech Drug Market Size by Country (2018-2024)
9.4 Latin America Biotech Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biotech Drug Market Size (2018-2029)
10.2 Middle East & Africa Biotech Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Biotech Drug Market Size by Country (2018-2024)
10.4 Middle East & Africa Biotech Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Biotech Drug Introduction
11.1.4 Roche Revenue in Biotech Drug Business (2018-2024)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Biotech Drug Introduction
11.2.4 Amgen Revenue in Biotech Drug Business (2018-2024)
11.2.5 Amgen Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Detail
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Biotech Drug Introduction
11.3.4 AbbVie Revenue in Biotech Drug Business (2018-2024)
11.3.5 AbbVie Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Biotech Drug Introduction
11.4.4 Sanofi Revenue in Biotech Drug Business (2018-2024)
11.4.5 Sanofi Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Biotech Drug Introduction
11.5.4 Johnson & Johnson Revenue in Biotech Drug Business (2018-2024)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Biotech Drug Introduction
11.6.4 Pfizer Revenue in Biotech Drug Business (2018-2024)
11.6.5 Pfizer Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Detail
11.7.2 Novo Nordisk Business Overview
11.7.3 Novo Nordisk Biotech Drug Introduction
11.7.4 Novo Nordisk Revenue in Biotech Drug Business (2018-2024)
11.7.5 Novo Nordisk Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Detail
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Biotech Drug Introduction
11.8.4 Eli Lilly Revenue in Biotech Drug Business (2018-2024)
11.8.5 Eli Lilly Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis Biotech Drug Introduction
11.9.4 Novartis Revenue in Biotech Drug Business (2018-2024)
11.9.5 Novartis Recent Development
11.10 Merck
11.10.1 Merck Company Detail
11.10.2 Merck Business Overview
11.10.3 Merck Biotech Drug Introduction
11.10.4 Merck Revenue in Biotech Drug Business (2018-2024)
11.10.5 Merck Recent Development
11.11 Biogen
11.11.1 Biogen Company Detail
11.11.2 Biogen Business Overview
11.11.3 Biogen Biotech Drug Introduction
11.11.4 Biogen Revenue in Biotech Drug Business (2018-2024)
11.11.5 Biogen Recent Development
11.12 Celltrion
11.12.1 Celltrion Company Detail
11.12.2 Celltrion Business Overview
11.12.3 Celltrion Biotech Drug Introduction
11.12.4 Celltrion Revenue in Biotech Drug Business (2018-2024)
11.12.5 Celltrion Recent Development
11.13 Sobi
11.13.1 Sobi Company Detail
11.13.2 Sobi Business Overview
11.13.3 Sobi Biotech Drug Introduction
11.13.4 Sobi Revenue in Biotech Drug Business (2018-2024)
11.13.5 Sobi Recent Development
11.14 3SBIO
11.14.1 3SBIO Company Detail
11.14.2 3SBIO Business Overview
11.14.3 3SBIO Biotech Drug Introduction
11.14.4 3SBIO Revenue in Biotech Drug Business (2018-2024)
11.14.5 3SBIO Recent Development
11.15 Changchun High Tech
11.15.1 Changchun High Tech Company Detail
11.15.2 Changchun High Tech Business Overview
11.15.3 Changchun High Tech Biotech Drug Introduction
11.15.4 Changchun High Tech Revenue in Biotech Drug Business (2018-2024)
11.15.5 Changchun High Tech Recent Development
11.16 Kanghong Pharma
11.16.1 Kanghong Pharma Company Detail
11.16.2 Kanghong Pharma Business Overview
11.16.3 Kanghong Pharma Biotech Drug Introduction
11.16.4 Kanghong Pharma Revenue in Biotech Drug Business (2018-2024)
11.16.5 Kanghong Pharma Recent Development
11.17 Innovent Biologics
11.17.1 Innovent Biologics Company Detail
11.17.2 Innovent Biologics Business Overview
11.17.3 Innovent Biologics Biotech Drug Introduction
11.17.4 Innovent Biologics Revenue in Biotech Drug Business (2018-2024)
11.17.5 Innovent Biologics Recent Development
11.18 Gan&Lee
11.18.1 Gan&Lee Company Detail
11.18.2 Gan&Lee Business Overview
11.18.3 Gan&Lee Biotech Drug Introduction
11.18.4 Gan&Lee Revenue in Biotech Drug Business (2018-2024)
11.18.5 Gan&Lee Recent Development
11.19 Tonghua Dongbao
11.19.1 Tonghua Dongbao Company Detail
11.19.2 Tonghua Dongbao Business Overview
11.19.3 Tonghua Dongbao Biotech Drug Introduction
11.19.4 Tonghua Dongbao Revenue in Biotech Drug Business (2018-2024)
11.19.5 Tonghua Dongbao Recent Development
11.20 United Laboratory
11.20.1 United Laboratory Company Detail
11.20.2 United Laboratory Business Overview
11.20.3 United Laboratory Biotech Drug Introduction
11.20.4 United Laboratory Revenue in Biotech Drug Business (2018-2024)
11.20.5 United Laboratory Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Biotech Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Interferon
Table 4. Key Players of Insulin
Table 5. Key Players of Vaccines
Table 6. Key Players of Others
Table 7. Global Biotech Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Biotech Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Biotech Drug Market Size by Region (2018-2024) & (US$ Million)
Table 10. Global Biotech Drug Market Share by Region (2018-2024)
Table 11. Global Biotech Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Biotech Drug Market Share by Region (2024-2029)
Table 13. Biotech Drug Market Trends
Table 14. Biotech Drug Market Drivers
Table 15. Biotech Drug Market Challenges
Table 16. Biotech Drug Market Restraints
Table 17. Global Biotech Drug Revenue by Players (2018-2024) & (US$ Million)
Table 18. Global Biotech Drug Market Share by Players (2018-2024)
Table 19. Global Top Biotech Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotech Drug as of 2022)
Table 20. Ranking of Global Top Biotech Drug Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Biotech Drug Revenue (CR5 and HHI) & (2018-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Biotech Drug Product Solution and Service
Table 24. Date of Enter into Biotech Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Biotech Drug Market Size by Type (2018-2024) & (US$ Million)
Table 27. Global Biotech Drug Revenue Market Share by Type (2018-2024)
Table 28. Global Biotech Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Biotech Drug Revenue Market Share by Type (2024-2029)
Table 30. Global Biotech Drug Market Size by Application (2018-2024) & (US$ Million)
Table 31. Global Biotech Drug Revenue Market Share by Application (2018-2024)
Table 32. Global Biotech Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Biotech Drug Revenue Market Share by Application (2024-2029)
Table 34. North America Biotech Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Biotech Drug Market Size by Country (2018-2024) & (US$ Million)
Table 36. North America Biotech Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Biotech Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Biotech Drug Market Size by Country (2018-2024) & (US$ Million)
Table 39. Europe Biotech Drug Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Biotech Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Biotech Drug Market Size by Region (2018-2024) & (US$ Million)
Table 42. Asia-Pacific Biotech Drug Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Biotech Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Biotech Drug Market Size by Country (2018-2024) & (US$ Million)
Table 45. Latin America Biotech Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Biotech Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Biotech Drug Market Size by Country (2018-2024) & (US$ Million)
Table 48. Middle East & Africa Biotech Drug Market Size by Country (2024-2029) & (US$ Million)
Table 49. Roche Company Detail
Table 50. Roche Business Overview
Table 51. Roche Biotech Drug Product
Table 52. Roche Revenue in Biotech Drug Business (2018-2024) & (US$ Million)
Table 53. Roche Recent Development
Table 54. Amgen Company Detail
Table 55. Amgen Business Overview
Table 56. Amgen Biotech Drug Product
Table 57. Amgen Revenue in Biotech Drug Business (2018-2024) & (US$ Million)
Table 58. Amgen Recent Development
Table 59. AbbVie Company Detail
Table 60. AbbVie Business Overview
Table 61. AbbVie Biotech Drug Product
Table 62. AbbVie Revenue in Biotech Drug Business (2018-2024) & (US$ Million)
Table 63. AbbVie Recent Development
Table 64. Sanofi Company Detail
Table 65. Sanofi Business Overview
Table 66. Sanofi Biotech Drug Product
Table 67. Sanofi Revenue in Biotech Drug Business (2018-2024) & (US$ Million)
Table 68. Sanofi Recent Development
Table 69. Johnson & Johnson Company Detail
Table 70. Johnson & Johnson Business Overview
Table 71. Johnson & Johnson Biotech Drug Product
Table 72. Johnson & Johnson Revenue in Biotech Drug Business (2018-2024) & (US$ Million)
Table 73. Johnson & Johnson Recent Development
Table 74. Pfizer Company Detail
Table 75. Pfizer Business Overview
Table 76. Pfizer Biotech Drug Product
Table 77. Pfizer Revenue in Biotech Drug Business (2018-2024) & (US$ Million)
Table 78. Pfizer Recent Development
Table 79. Novo Nordisk Company Detail
Table 80. Novo Nordisk Business Overview
Table 81. Novo Nordisk Biotech Drug Product
Table 82. Novo Nordisk Revenue in Biotech Drug Business (2018-2024) & (US$ Million)
Table 83. Novo Nordisk Recent Development
Table 84. Eli Lilly Company Detail
Table 85. Eli Lilly Business Overview
Table 86. Eli Lilly Biotech Drug Product
Table 87. Eli Lilly Revenue in Biotech Drug Business (2018-2024) & (US$ Million)
Table 88. Eli Lilly Recent Development
Table 89. Novartis Company Detail
Table 90. Novartis Business Overview
Table 91. Novartis Biotech Drug Product
Table 92. Novartis Revenue in Biotech Drug Business (2018-2024) & (US$ Million)
Table 93. Novartis Recent Development
Table 94. Merck Company Detail
Table 95. Merck Business Overview
Table 96. Merck Biotech Drug Product
Table 97. Merck Revenue in Biotech Drug Business (2018-2024) & (US$ Million)
Table 98. Merck Recent Development
Table 99. Biogen Company Detail
Table 100. Biogen Business Overview
Table 101. Biogen Biotech Drug Product
Table 102. Biogen Revenue in Biotech Drug Business (2018-2024) & (US$ Million)
Table 103. Biogen Recent Development
Table 104. Celltrion Company Detail
Table 105. Celltrion Business Overview
Table 106. Celltrion Biotech Drug Product
Table 107. Celltrion Revenue in Biotech Drug Business (2018-2024) & (US$ Million)
Table 108. Celltrion Recent Development
Table 109. Sobi Company Detail
Table 110. Sobi Business Overview
Table 111. Sobi Biotech Drug Product
Table 112. Sobi Revenue in Biotech Drug Business (2018-2024) & (US$ Million)
Table 113. Sobi Recent Development
Table 114. 3SBIO Company Detail
Table 115. 3SBIO Business Overview
Table 116. 3SBIO Biotech Drug Product
Table 117. 3SBIO Revenue in Biotech Drug Business (2018-2024) & (US$ Million)
Table 118. 3SBIO Recent Development
Table 119. Changchun High Tech Company Detail
Table 120. Changchun High Tech Business Overview
Table 121. Changchun High Tech Biotech Drug Product
Table 122. Changchun High Tech Revenue in Biotech Drug Business (2018-2024) & (US$ Million)
Table 123. Changchun High Tech Recent Development
Table 124. Kanghong Pharma Company Detail
Table 125. Kanghong Pharma Business Overview
Table 126. Kanghong Pharma Biotech Drug Product
Table 127. Kanghong Pharma Revenue in Biotech Drug Business (2018-2024) & (US$ Million)
Table 128. Kanghong Pharma Recent Development
Table 129. Innovent Biologics Company Detail
Table 130. Innovent Biologics Business Overview
Table 131. Innovent Biologics Biotech Drug Product
Table 132. Innovent Biologics Revenue in Biotech Drug Business (2018-2024) & (US$ Million)
Table 133. Innovent Biologics Recent Development
Table 134. Gan&Lee Company Detail
Table 135. Gan&Lee Business Overview
Table 136. Gan&Lee Biotech Drug Product
Table 137. Gan&Lee Revenue in Biotech Drug Business (2018-2024) & (US$ Million)
Table 138. Gan&Lee Recent Development
Table 139. Tonghua Dongbao Company Detail
Table 140. Tonghua Dongbao Business Overview
Table 141. Tonghua Dongbao Biotech Drug Product
Table 142. Tonghua Dongbao Revenue in Biotech Drug Business (2018-2024) & (US$ Million)
Table 143. Tonghua Dongbao Recent Development
Table 144. United Laboratory Company Detail
Table 145. United Laboratory Business Overview
Table 146. United Laboratory Biotech Drug Product
Table 147. United Laboratory Revenue in Biotech Drug Business (2018-2024) & (US$ Million)
Table 148. United Laboratory Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biotech Drug Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Biotech Drug Market Share by Type: 2022 VS 2029
Figure 3. Monoclonal Antibodies Features
Figure 4. Interferon Features
Figure 5. Insulin Features
Figure 6. Vaccines Features
Figure 7. Others Features
Figure 8. Global Biotech Drug Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 9. Global Biotech Drug Market Share by Application: 2022 VS 2029
Figure 10. Hospital Case Studies
Figure 11. Retail Pharmacy Case Studies
Figure 12. Other Case Studies
Figure 13. Biotech Drug Report Years Considered
Figure 14. Global Biotech Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Biotech Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Biotech Drug Market Share by Region: 2022 VS 2029
Figure 17. Global Biotech Drug Market Share by Players in 2022
Figure 18. Global Top Biotech Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotech Drug as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Biotech Drug Revenue in 2022
Figure 20. North America Biotech Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Biotech Drug Market Share by Country (2018-2029)
Figure 22. United States Biotech Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Biotech Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Biotech Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Biotech Drug Market Share by Country (2018-2029)
Figure 26. Germany Biotech Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Biotech Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Biotech Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Biotech Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Biotech Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Biotech Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Biotech Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Biotech Drug Market Share by Region (2018-2029)
Figure 34. China Biotech Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Biotech Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Biotech Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Biotech Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Biotech Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Biotech Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Biotech Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Biotech Drug Market Share by Country (2018-2029)
Figure 42. Mexico Biotech Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Biotech Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Biotech Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Biotech Drug Market Share by Country (2018-2029)
Figure 46. Turkey Biotech Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Biotech Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Roche Revenue Growth Rate in Biotech Drug Business (2018-2024)
Figure 49. Amgen Revenue Growth Rate in Biotech Drug Business (2018-2024)
Figure 50. AbbVie Revenue Growth Rate in Biotech Drug Business (2018-2024)
Figure 51. Sanofi Revenue Growth Rate in Biotech Drug Business (2018-2024)
Figure 52. Johnson & Johnson Revenue Growth Rate in Biotech Drug Business (2018-2024)
Figure 53. Pfizer Revenue Growth Rate in Biotech Drug Business (2018-2024)
Figure 54. Novo Nordisk Revenue Growth Rate in Biotech Drug Business (2018-2024)
Figure 55. Eli Lilly Revenue Growth Rate in Biotech Drug Business (2018-2024)
Figure 56. Novartis Revenue Growth Rate in Biotech Drug Business (2018-2024)
Figure 57. Merck Revenue Growth Rate in Biotech Drug Business (2018-2024)
Figure 58. Biogen Revenue Growth Rate in Biotech Drug Business (2018-2024)
Figure 59. Celltrion Revenue Growth Rate in Biotech Drug Business (2018-2024)
Figure 60. Sobi Revenue Growth Rate in Biotech Drug Business (2018-2024)
Figure 61. 3SBIO Revenue Growth Rate in Biotech Drug Business (2018-2024)
Figure 62. Changchun High Tech Revenue Growth Rate in Biotech Drug Business (2018-2024)
Figure 63. Kanghong Pharma Revenue Growth Rate in Biotech Drug Business (2018-2024)
Figure 64. Innovent Biologics Revenue Growth Rate in Biotech Drug Business (2018-2024)
Figure 65. Gan&Lee Revenue Growth Rate in Biotech Drug Business (2018-2024)
Figure 66. Tonghua Dongbao Revenue Growth Rate in Biotech Drug Business (2018-2024)
Figure 67. United Laboratory Revenue Growth Rate in Biotech Drug Business (2018-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed